Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-24

Clinical Trial Update: Propranolol in Treating Hypoglycemia Unawareness [Phase 2]

View source ↗

Summary

Phase 2 trial investigating propranolol for hypoglycemia unawareness in type 1 diabetes was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: Anu Sharma | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2020-08-24